Certain anxiolytics, such as selective serotonin reuptake inhibitors (SSRIs), can modulate neurotransmitter signaling in Visual Snow Syndrome by increasing serotonin availability and potentially reducing cortical hyperexcitability. These medications may help mitigate associated symptoms by stabilizing neuronal activity and reducing the sensory processing aberrations characteristic of the syndrome, though their efficacy is primarily symptomatic rather than curative.